These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9387294

  • 21. Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid.
    Wu S, Zhang ZP, Zhang D, Soprano DR, Soprano KJ.
    Exp Cell Res; 1997 Nov 25; 237(1):118-26. PubMed ID: 9417874
    [Abstract] [Full Text] [Related]

  • 22. Estradiol regulation of the human retinoic acid receptor alpha gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs.
    Rishi AK, Shao ZM, Baumann RG, Li XS, Sheikh MS, Kimura S, Bashirelahi N, Fontana JA.
    Cancer Res; 1995 Nov 01; 55(21):4999-5006. PubMed ID: 7585542
    [Abstract] [Full Text] [Related]

  • 23. Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid.
    Wu S, Zhang D, Zhang ZP, Soprano DR, Soprano KJ.
    Oncogene; 1998 Dec 03; 17(22):2839-49. PubMed ID: 9879990
    [Abstract] [Full Text] [Related]

  • 24. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function.
    van der Burg B, van der Leede BM, Kwakkenbos-Isbrücker L, Salverda S, de Laat SW, van der Saag PT.
    Mol Cell Endocrinol; 1993 Feb 03; 91(1-2):149-57. PubMed ID: 8386111
    [Abstract] [Full Text] [Related]

  • 25. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
    Rousseau C, Nichol JN, Pettersson F, Couture MC, Miller WH.
    Mol Cancer Res; 2004 Sep 03; 2(9):523-31. PubMed ID: 15383631
    [Abstract] [Full Text] [Related]

  • 26. Retinoic acid nuclear receptor beta inhibits breast carcinoma anchorage independent growth.
    Li XS, Shao ZM, Sheikh MS, Eiseman JL, Sentz D, Jetten AM, Chen JC, Dawson MI, Aisner S, Rishi AK.
    J Cell Physiol; 1995 Dec 03; 165(3):449-58. PubMed ID: 7593223
    [Abstract] [Full Text] [Related]

  • 27. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells.
    Zhao Z, Zhang ZP, Soprano DR, Soprano KJ.
    Exp Cell Res; 1995 Aug 03; 219(2):555-61. PubMed ID: 7641808
    [Abstract] [Full Text] [Related]

  • 28. Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex.
    Sun G, Porter W, Safe S.
    Mol Endocrinol; 1998 Jun 03; 12(6):882-90. PubMed ID: 9626663
    [Abstract] [Full Text] [Related]

  • 29. Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells.
    Widschwendter M, Daxenbichler G, Dapunt O, Marth C.
    Cancer Res; 1995 May 15; 55(10):2135-9. PubMed ID: 7743514
    [Abstract] [Full Text] [Related]

  • 30. [Retinoic acid nuclear receptor beta (RAR beta) inhibits breast carcinoma growth].
    Shao Z, Shen Z.
    Zhonghua Zhong Liu Za Zhi; 1996 Sep 15; 18(5):324-7. PubMed ID: 9387266
    [Abstract] [Full Text] [Related]

  • 31. Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells.
    Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K.
    Cell Growth Differ; 1995 Sep 15; 6(9):1077-88. PubMed ID: 8519684
    [Abstract] [Full Text] [Related]

  • 32. Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells.
    Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A, Mira-Y-Lopez R.
    Cell Growth Differ; 2002 Aug 15; 13(8):335-41. PubMed ID: 12193472
    [Abstract] [Full Text] [Related]

  • 33. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
    Dawson MI, Chao WR, Pine P, Jong L, Hobbs PD, Rudd CK, Quick TC, Niles RM, Zhang XK, Lombardo A.
    Cancer Res; 1995 Oct 01; 55(19):4446-51. PubMed ID: 7671258
    [Abstract] [Full Text] [Related]

  • 34. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells.
    Sonneveld E, van den Brink CE, van der Leede BM, Schulkes RK, Petkovich M, van der Burg B, van der Saag PT.
    Cell Growth Differ; 1998 Aug 01; 9(8):629-37. PubMed ID: 9716180
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line.
    Wan YJ, Cai Y, Magee TR.
    Exp Cell Res; 1998 Jan 10; 238(1):241-7. PubMed ID: 9457077
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Overexpression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition.
    Soprano DR, Chen LX, Wu S, Donigan AM, Borghaei RC, Soprano KJ.
    Oncogene; 1996 Feb 01; 12(3):577-84. PubMed ID: 8637715
    [Abstract] [Full Text] [Related]

  • 40. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E.
    Oncogene; 1995 Jun 15; 10(12):2307-14. PubMed ID: 7784078
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.